Pharma Biz Hits Back At Takeda In Clash Over ADHD Drug IP
Pharmaceutical company Aristo has doubled down on its attempt to squash Takeda's extended patent protections that cover ADHD drug Elvanse, telling a London court that it still plans to launch a...To view the full article, register now.
Already a subscriber? Click here to view full article